Farther Finance Advisors, LLC

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 1992825 SAN FRANCISCO, CA

Position in ARWR

as of Sep 30, 2026 · filed Oct 8, 2026 Compact

Position Value

$795,021

-$190,271 QoQ

Shares Held

12,147

+0.5% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

of 8 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Sep 30, 2026

Farther Finance Advisors, LLC holds $27,307,338 across 327 Biotechnology names. ARWR ranks #8 (2.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	9,471	$4,951,533
2	MRNA	Moderna, Inc.	17,622	$3,393,468
3	HALO	Halozyme Therapeutics, Inc.	11,074	$1,222,569
4	REGN	Regeneron Pharmaceuticals, Inc.	1,534	$1,163,186
5	INCY	Incyte Corp	9,256	$1,123,215
6	EXEL	Exelixis, Inc.	18,290	$1,068,318
7	RVMD	Revolution Medicines, Inc.	4,848	$995,100
8	ARWR	Arrowhead Pharmaceuticals, Inc. This page	12,147	$795,021

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-09-30	$795,021	12,147	+0.5%	Shares	Sole	2026-10-08
2026-06-30	$985,292	12,088	+1.0%	Shares	Sole	2026-07-17
2026-03-31	$750,581	11,971	+0.3%	Shares	Sole	2026-04-07
2025-12-31	$792,762	11,941	+2923.0%	Shares	Sole	2026-01-23
2025-09-30	$13,623	395	+758.7%	Shares	Sole	2025-10-14
2025-06-30	$726	46	-72.1%	Shares	Sole	2025-07-11
2025-03-31	$2,102	165	+275.0%	Shares	Sole	2025-04-14
2024-12-31	$827	44	-15.4%	Shares	Sole	2025-02-10
2024-09-30	$1,007	52	-73.7%	Shares	Sole	2024-10-29
2024-06-30	$5,146	198	-4.3%	Shares	Sole	2024-07-31
2024-03-31	$5,920	207	+2.5%	Shares	Sole	2024-05-14
2023-12-31	$6,181	202	+24.7%	Shares	Sole	2024-02-15
2023-06-30	$5,776	162	-14.3%	Shares	Sole	2024-05-14
2023-03-31	$4,800	189	+2600.0%	Shares	Sole	2024-05-14
2022-12-31	$283	7	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.